Articles

Canopy Growth, Tilray move up in premarket trades after dramatic rally on DEA’s plan to make pot a Schedule III controlled substance

The company lowered its revenue-growth forecast for 2024 and showed a slowdown in volume growth for April.

Yum Brands’ CEO David Gibbs described “a difficult operating environment” during the first quarter.

The Treasury Department on Wednesday said it would sell $125 billion in notes and bonds next week. That’s the same as  was offered last quarter.

Pfizer on Wednesday reported first-quarter results that beat analyst expectations, and raised its full-year profit guidance as cancer and heart-disease drugs helped offset plummeting COVID product sales.

U.S. businesses created 192,000 new jobs in April, paycheck company ADP said, and more industries hired people last month in a sign of ongoing labor-market strength.

CVS Health’s stock tumbled in premarket trading Wednesday, after the drugstore chain and healthcare-services company missed first-quarter earnings expectations amid challenges in its health services and Medicare businesses and rising costs.

The Transportation Department said this gives consumers clearer rights rather than making them rely on airlines to decide when compensation is owed

Our call of the day from TS Lombard flags worrying signs on the labor market, and Asian currencies that need things to go just right for the U.S. economy.

The plan is expected to resolve 99.75% of all pending talc lawsuits against the company and its units in the U.S., it said in a statement.

Why 2024 will be a year of sizeable growth for the chip maker.

Americans are on a frustrating search for a soft economic landing.